---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-024065"
form_type: "8-K"
ticker: "XENE"
cik: "0001582313"
company_name: "Xenon Pharmaceuticals Inc."
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:39:15.496522+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Xenon Pharmaceuticals announces public offering of 7.87M shares and pre-funded warrants for net proceeds of ~$234.6M

## Summary
- Offering of 7,868,854 common shares and pre-funded warrants for 327,868 shares at $30.50/share and $30.4999/warrant.
- Net proceeds expected ~$234.6M after underwriting discounts and estimated expenses.
- Underwriters granted 30-day option to purchase up to 1,229,508 additional common shares at $28.67/share.
- Pre-funded warrants exercisable immediately at $0.0001 per share until exercised in full.

## SEC filing metadata
- accession: 0001564590-22-024065
- form_type: 8-K
- ticker: XENE
- cik: 0001582313
- company_name: Xenon Pharmaceuticals Inc.
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582313/000156459022024065/0001564590-22-024065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582313/000156459022024065/xene-8k_20220622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-024065
- JSON: https://secwatch.observer/filing/0001564590-22-024065.json
- Plain text: https://secwatch.observer/filing/0001564590-22-024065.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.